BCL10 antibody (N-Term) (APC)
Quick Overview for BCL10 antibody (N-Term) (APC) (ABIN2209255)
Target
See all BCL10 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 27-55, N-Term
-
Cross-Reactivity
- Human, Mouse (Murine)
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu Mo
-
Characteristics
- BCL10, NT (BCL10, CIPER, CLAP, B Cell lymphoma/leukemia 10, B Cell CLL/lymphoma 10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, Cellular-E10, Mammalian CARD-containing adapter molecule E10) (APC)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogen
- BCL10 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 27-55 amino acids from the N-terminal region of human BCL10.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Storage
- 4 °C
-
Storage Comment
- 4°C ,Do Not Freeze
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Alternative Name
- BCL10
-
NCBI Accession
- NP_003912
-
UniProt
- O95999
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
Target
-